Evidence map›Paper›PMID 41569417›Full record

ArticleNeuroradiology2026

Deep learning-accelerated 3D flair for white matter lesion detection in multiple sclerosis: a feasibility study.

Pranjal Rai, Vincent Ern Yao Chan, Marcel Dominik Nickel, Cem Bilgin, Peter Kollasch, Kara Dueker, Theodore J Passe, Steven A Messina, Victoria M Silvera, Amit Agarwal and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Neuroradiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Pranjal RaiMayo Clinic, Rochester, United States. raipranjal2@gmail.com.
Vincent Ern Yao ChanMayo Clinic, Rochester, United States.
Marcel Dominik NickelSiemens Healthineers (Germany), Eschborn, Germany.
Cem BilginMayo Clinic, Rochester, United States.
Peter KollaschSiemens Healthineers (United States), Rochester, United States.
Kara DuekerSiemens Healthineers (United States), Rochester, United States.
Theodore J PasseMayo Clinic, Rochester, United States.
Steven A MessinaMayo Clinic, Rochester, United States.
Victoria M SilveraMayo Clinic, Rochester, United States.
Amit AgarwalThe University of Texas MD Anderson Cancer Center, Houston, United States.
Girish BathlaMayo Clinic, Rochester, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesDeep learning (DL)-based image reconstruction (DLBIR) techniques promise accelerated MRI acquisitions with enhanced image quality. Herein, we compare the image quality of a DLBIR-based 3D FLAIR (3D-FLAIR MATERIALS AND

methodsOur prospective, reader-blinded study, included 26 MS patients who underwent both sequences on a 3T scanner during the same study session over three months. Two neuroradiologists assessed noise, artifacts, sharpness, overall image quality, and diagnostic confidence using 4-point Likert-like scales. Lesion conspicuity was graded for lesions < 3 mm and ≥ 3 mm. Quantitative metrics included lesion count, apparent signal-to-noise ratio (aSNR), and contrast-to-noise ratio (aCNR). A composite gold standard was used to calculate sensitivity and precision.

results3D-FLAIR

conclusionDLBIR 3D FLAIR significantly improves lesion detection and image quality in MS, supporting its potential integration into standard imaging protocols. As DLBIR algorithms evolve, further validation in larger, diverse cohorts will be essential.

Indexed as

Deep LearningImaging, Three-DimensionalMagnetic Resonance ImagingMultiple SclerosisWhite MatterAdultFeasibility StudiesFemaleHumansImage Interpretation, Computer-AssistedMaleMiddle AgedProspective StudiesSensitivity and SpecificityDeep-learningImage accelerationMRIMultiple sclerosisWhite matter lesion

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.